| CUBE-OPERATIONS-LLC |
CUBE-OPERATIONS-LLC |
92%
|
The Agreement and the Order Form are by and between Mango DAT, LLC and Cube Operations LLC |
| BRIGHTERMD-LLC |
BRIGHTERMD-LLC |
85%
|
tains control of the products upon the Company’s completion of its performance obligation. The Company has entered into a Physician Services Agreement with BrighterMD, LLC dba Doctegrity (“Doctegrity… |
| NAVY-WHARF-LTD |
NAVY-WHARF-LTD |
85%
|
. Renewal beyond the initial 3-year term cannot be guaranteed. Fair value of distribution rights based on discounted cash flows over the initial term is less than the $ 1,362,447 carrying value. An i… |
| HIMS |
Hims & Hers Health, Inc. |
72%
|
Reciprocal relationship from HIMS graph: Reciprocal relationship from MGRX graph: Reciprocal relationship from HIMS graph: Reciprocal relationship from MGRX graph: rowth strategy and scale our operat… |
| HIMS |
Hims & Hers Health, Inc. |
72%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| JNJ |
Johnson & Johnson |
72%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from MGRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from MGRX graph: Reciprocal relationship from JNJ grap… |
| LLY |
Eli Lilly and Company |
72%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| LLY |
Eli Lilly and Company |
72%
|
Reciprocal relationship from LLY graph: Reciprocal relationship from MGRX graph: Reciprocal relationship from LLY graph: Reciprocal relationship from MGRX graph: Reciprocal relationship from LLY grap… |
| AMERICAN-INTERNATIONAL-HOLDINGS-CORP |
AMERICAN-INTERNATIONAL-HOLDINGS-CORP |
62%
|
d. The Telemedicine Providers’ physicians are tasked with determining whether patients seeking our Pharmaceutical Products are eligible to be prescribed our Pharmaceutical Products, with the sole pur… |
| BARSTOOL-SPORTS-INC |
BARSTOOL-SPORTS-INC |
62%
|
currently anticipate such funding being raised through the offering of debt or equity. Such additional financing, if required, may not be available on favorable terms, if at all. If debt financing is… |
| BOUSTEAD-SECURITIES-LLC |
BOUSTEAD-SECURITIES-LLC |
62%
|
currently anticipate such funding being raised through the offering of debt or equity. Such additional financing, if required, may not be available on favorable terms, if at all. If debt financing is… |
| COHEN-ENTERPRISES-INC |
COHEN-ENTERPRISES-INC |
62%
|
currently anticipate such funding being raised through the offering of debt or equity. Such additional financing, if required, may not be available on favorable terms, if at all. If debt financing is… |
| EMERGING-GROWTH-COMPANY |
EMERGING-GROWTH-COMPANY |
62%
|
y are a number of proposals pending before federal, state, and foreign legislative and regulatory bodies. Product Liability As a distributor of men’s health and wellness products, the Company faces a… |
| EPIQ-SCRIPTS-LLC |
EPIQ-SCRIPTS-LLC |
62%
|
we have entered into an agreement with may not receive licenses in all of the 50 United States to provide national coverage for us to sell our Pharmaceutical Products and future products. We have ent… |
| HERS-HEALTH-INC |
HERS-HEALTH-INC |
62%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| ICOS-CORPORATION |
ICOS-CORPORATION |
62%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| LILLY-ICOS-LLC |
LILLY-ICOS-LLC |
62%
|
rowth strategy and scale our operations and risks associated with such growth, and our ability to attract members and customers; ● The effect of pandemics and governmental responses thereto on our op… |
| MAAB-GLOBAL-LTD |
MAAB-GLOBAL-LTD |
62%
|
currently anticipate such funding being raised through the offering of debt or equity. Such additional financing, if required, may not be available on favorable terms, if at all. If debt financing is… |
| MANGO-DAT-LLC |
MANGO-DAT-LLC |
62%
|
ent that the Company reimburse certain expenses of Epiq Scripts, subject to certain limitations and pre-approvals. No payments under the Consulting Agreement have been made to date. Marketing Agreeme… |
| MANGORX-IP-HOLDINGS-LLC |
MANGORX-IP-HOLDINGS-LLC |
62%
|
ent that the Company reimburse certain expenses of Epiq Scripts, subject to certain limitations and pre-approvals. No payments under the Consulting Agreement have been made to date. Marketing Agreeme… |
| MANGORX-UK-LIMITED |
MANGORX-UK-LIMITED |
62%
|
we have entered into an agreement with may not receive licenses in all of the 50 United States to provide national coverage for us to sell our Pharmaceutical Products and future products. We have ent… |
| MARIUS-PHARMACEUTICALS-LLC |
MARIUS-PHARMACEUTICALS-LLC |
62%
|
ent that the Company reimburse certain expenses of Epiq Scripts, subject to certain limitations and pre-approvals. No payments under the Consulting Agreement have been made to date. Marketing Agreeme… |
| MEXICAN-STOCK-COMPANY |
MEXICAN-STOCK-COMPANY |
62%
|
we have entered into an agreement with may not receive licenses in all of the 50 United States to provide national coverage for us to sell our Pharmaceutical Products and future products. We have ent… |
| MILL-END-CAPITAL-LTD |
MILL-END-CAPITAL-LTD |
62%
|
currently anticipate such funding being raised through the offering of debt or equity. Such additional financing, if required, may not be available on favorable terms, if at all. If debt financing is… |
| PREVENTECH-SOLUTIONS-LLC |
PREVENTECH-SOLUTIONS-LLC |
62%
|
ent that the Company reimburse certain expenses of Epiq Scripts, subject to certain limitations and pre-approvals. No payments under the Consulting Agreement have been made to date. Marketing Agreeme… |
| PROPRE-ENERGIE-INC |
PROPRE-ENERGIE-INC |
62%
|
ent that the Company reimburse certain expenses of Epiq Scripts, subject to certain limitations and pre-approvals. No payments under the Consulting Agreement have been made to date. Marketing Agreeme… |
| RONIN-EQUITY-PARTNERS-INC |
RONIN-EQUITY-PARTNERS-INC |
62%
|
y be subject to varying interpretations by courts and government agencies, creating complex compliance issues for us and our clients and potentially exposing us to additional expense, adverse publici… |
| SECURITIES-INVESTOR-PROTECTION-CORPORATION |
SECURITIES-INVESTOR-PROTECTION-CORPORATION |
62%
|
d Epiq Scripts, LLC, a related party pharmacy. We have entered into agreements with our Telemedicine Providers, pursuant to which our Telemedicine Providers provide clinical services directly to our … |
| SVHQ-LLC |
SVHQ-LLC |
62%
|
are processed. Personal information required for integrations with external systems is encrypted using hash algorithms, further securing data at rest and in transit. These security practices highligh… |
